spacer
spacer

PDBsum entry 2bdh

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
2bdh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
223 a.a. *
Ligands
PBZ ×4
Metals
_ZN
Waters ×111
* Residue conservation analysis
PDB id:
2bdh
Name: Hydrolase
Title: Human kallikrein 4 complex with zinc and p-aminobenzamidine
Structure: Kallikrein-4. Chain: a, b, c, d. Fragment: human kallikrein 4. Synonym: prostase, kallikrein-like protein 1, klk-l1, enamel matrix serine proteinase 1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: klk4, emsp1, prss17, psts. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
3.00Å     R-factor:   0.233     R-free:   0.292
Authors: M.Debela,W.Bode,P.Goettig,Structural Proteomics In Europe (Spine)
Key ref:
M.Debela et al. (2006). Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J Mol Biol, 362, 1094-1107. PubMed id: 16950394 DOI: 10.1016/j.jmb.2006.08.003
Date:
20-Oct-05     Release date:   03-Oct-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9Y5K2  (KLK4_HUMAN) -  Kallikrein-4 from Homo sapiens
Seq:
Struc:
254 a.a.
223 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.3.4.21.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/j.jmb.2006.08.003 J Mol Biol 362:1094-1107 (2006)
PubMed id: 16950394  
 
 
Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
M.Debela, V.Magdolen, V.Grimminger, C.Sommerhoff, A.Messerschmidt, R.Huber, R.Friedrich, W.Bode, P.Goettig.
 
  ABSTRACT  
 
Human tissue kallikrein 4 (hK4) belongs to a 15-member family of closely related serine proteinases. hK4 is predominantly expressed in prostate, activates hK3/PSA, and is up-regulated in prostate and ovarian cancer. We have identified active monomers of recombinant hK4 besides inactive oligomers in solution. hK4 crystallised in the presence of zinc, nickel, and cobalt ions in three crystal forms containing cyclic tetramers and octamers. These structures display a novel metal site between His25 and Glu77 that links the 70-80 loop with the N-terminal segment. Micromolar zinc as present in prostatic fluid inhibits the enzymatic activity of hK4 against fluorogenic substrates. In our measurements, wild-type hK4 exhibited a zinc inhibition constant (IC50) of 16 microM including a permanent residual activity, in contrast to the zinc-independent mutants H25A and E77A. Since the Ile16 N terminus of wild-type hK4 becomes more accessible for acetylating agents in the presence of zinc, we propose that zinc affects the hK4 active site via the salt-bridge formed between the N terminus and Asp194 required for a functional active site. hK4 possesses an unusual 99-loop that creates a groove-like acidic S2 subsite. These findings explain the observed specificity of hK4 for the P1 to P4 substrate residues. Moreover, hK4 shows a negatively charged surface patch, which may represent an exosite for prime-side substrate recognition.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. (a) Stereo view of the oligomeric architecture in the P4[1]2[1]2 hK4-Zn form. One hK4 tetramer is located in the asymmetric unit, highlighted by a transparent surface. This arrangement is pseudo-symmetrical, in contrast to the symmetrical tetramers of the P4 form. Only one zinc ion is bound per tetramer, displayed as a pink ball with electron density representing an anomalous Fourier map contoured at 3σ. Molecules that are symmetry-related by a crystallographic 2-fold axis are depicted in the same color. Both tetramers sit back to back and contact each other with a flat interaction surface resulting in an octameric assembly. (b) Top view of the octamer from the P4[1]2[1]2 crystals rotated by 90° with respect to (a). (c) Stereo representation of the asymmetric unit in the hK4-Co P2[1] crystal form, which contains two hk4 octamers. One cobalt ion is bound per pseudo-symmetrical tetramer, indicated by an anomalous Fourier map.
Figure 6.
Figure 6. Stereo view of the Ni^2+-binding site in the 70–80 loop of hK4, superimposed by the equivalent segments of hK1 in grey. The Ni^2+ is shown as a cyan ball, bound by four water molecules, Glu77 O^ε, and His25 N^ε2. The Ni^2+ ligand contacts are depicted as dotted lines. The electron density accounting for the coordinating water molecules is contoured at 1.0σ and that around nickel at 5.0σ. The most significant difference between the compared loops is one helical turn in hK4.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2006, 362, 1094-1107) copyright 2006.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20180638 J.E.Swedberg, S.J.de Veer, and J.M.Harris (2010).
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
  Biol Chem, 391, 357-374.  
20180634 L.Seiz, M.Kotzsch, N.I.Grebenchtchikov, A.J.Geurts-Moespot, S.Fuessel, P.Goettig, A.Gkazepis, M.P.Wirth, M.Schmitt, A.Lossnitzer, F.C.Sweep, and V.Magdolen (2010).
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
  Biol Chem, 391, 391-401.  
20302517 N.Beaufort, K.Plaza, D.Utzschneider, A.Schwarz, J.M.Burkhart, S.Creutzburg, M.Debela, M.Schmitt, C.Ries, and V.Magdolen (2010).
Interdependence of kallikrein-related peptidases in proteolytic networks.
  Biol Chem, 391, 581-587.  
20337595 N.Beaufort, P.Seweryn, S.de Bentzmann, A.Tang, J.Kellermann, N.Grebenchtchikov, M.Schmitt, C.P.Sommerhoff, D.Pidard, and V.Magdolen (2010).
Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.
  Biochem J, 428, 473-482.  
20615447 P.Goettig, V.Magdolen, and H.Brandstetter (2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
  Biochimie, 92, 1546-1567.  
  20056842 V.Gratio, N.Beaufort, L.Seiz, J.Maier, G.D.Virca, M.Debela, N.Grebenchtchikov, V.Magdolen, and D.Darmoul (2010).
Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
  Am J Pathol, 176, 1452-1461.  
19388054 G.Spraggon, M.Hornsby, A.Shipway, D.C.Tully, B.Bursulaya, H.Danahay, J.L.Harris, and S.A.Lesley (2009).
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations.
  Protein Sci, 18, 1081-1094.
PDB codes: 3e0n 3e1x 3fvf 3gyl 3gym
18627286 A.J.Ramsay, J.C.Reid, M.N.Adams, H.Samaratunga, Y.Dong, J.A.Clements, and J.D.Hooper (2008).
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
  Biol Chem, 389, 653-668.  
18308730 A.J.Ramsay, Y.Dong, M.L.Hunt, M.Linn, H.Samaratunga, J.A.Clements, and J.D.Hooper (2008).
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
  J Biol Chem, 283, 12293-12304.  
18844454 J.A.Clements (2008).
Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
  Biol Chem, 389, 1447-1454.  
18627343 M.Debela, N.Beaufort, V.Magdolen, N.M.Schechter, C.S.Craik, M.Schmitt, W.Bode, and P.Goettig (2008).
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
  Biol Chem, 389, 623-632.  
18817802 S.Liu, M.Z.Sun, C.Sun, B.Zhao, F.T.Greenaway, and Q.Zheng (2008).
A novel serine protease from the snake venom of Agkistrodon blomhoffii ussurensis.
  Toxicon, 52, 760-768.  
17976015 C.A.Borgoño, J.A.Gavigan, J.Alves, B.Bowles, J.L.Harris, G.Sotiropoulou, and E.P.Diamandis (2007).
Defining the extended substrate specificity of kallikrein 1-related peptidases.
  Biol Chem, 388, 1215-1225.  
17195012 C.Becker-Pauly, M.Höwel, T.Walker, A.Vlad, K.Aufenvenne, V.Oji, D.Lottaz, E.E.Sterchi, M.Debela, V.Magdolen, H.Traupe, and W.Stöcker (2007).
The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation.
  J Invest Dermatol, 127, 1115-1125.  
17890078 I.Botos, and A.Wlodawer (2007).
The expanding diversity of serine hydrolases.
  Curr Opin Struct Biol, 17, 683-690.  
17909180 M.Debela, P.Hess, V.Magdolen, N.M.Schechter, T.Steiner, R.Huber, W.Bode, and P.Goettig (2007).
Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7.
  Proc Natl Acad Sci U S A, 104, 16086-16091.
PDB codes: 2qxg 2qxh 2qxi 2qxj
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer